Skip to main content
  • Saved

made a Post

Comparing impact of SGLT2 inhibitors and GLP-1 agonists on lipid profile among the patients with diabetes mellitus Type 2. Results of a prospective 18-week observational study

Source :

https://www.endocrine-abstracts.org/ea/0073/ea0073aep305

1Tbilisi Heart and Vascular Clinic, Tblisi, Gerogia; 2National institute of Endocrinology, Tblisi, Georgia; 3Clinic 'ENMEDIC', Tblisi, Georgia; 4 'Family Doctor', Tblisi, Georgia Background In Georgia, significantly huge number of patients with Diabetes Mellitus Type 2 (DMT2) suffer from cardiovascular diseases (CVD) and obesity.